Pharmacologic controversy of CNS stimulants in Gilles de la Tourette's syndrome

Clinical Neuropharmacology

Volumn 15, Issue 5, 1992, Pages 408-425

  Robertson, M M ^a   Eapen, V ^a  

^a MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Attention deficit hyperactivity disorder; CNS; Gilles de la Tourette's syndrome; Stimulants

Indexed keywords

AMPHETAMINE; CENTRAL STIMULANT AGENT; CLONIDINE; DEXAMPHETAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; METHYLPHENIDATE; PEMOLINE MAGNESIUM;

ATTENTION DEFICIT DISORDER; BEHAVIOR; CLINICAL FEATURE; DRUG CHOICE; DRUG EFFICACY; DRUG USE; FAMILIAL DISEASE; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPERACTIVITY; INHERITANCE; NEUROCHEMISTRY; NEUROPHYSIOLOGY; NEUROTRANSMISSION; ONSET AGE; PRIORITY JOURNAL; REVIEW; TIC;

EID: 0026705587     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-199210000-00010     Document Type: Review

References (0)